Darwin Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$309K Sell
335
-36
-10% -$36.5K 0.1% 116
2025
Q4
$399K Sell
371
-2
-0.5% -$1.91K 0.12% 104
2025
Q3
$285K Buy
373
+13
+4% +$9.67K 0.09% 120
2025
Q2
$281K Sell
360
-15
-4% -$11.7K 0.1% 113
2025
Q1
$290K Hold
375
0.1% 114
2024
Q4
$290K Sell
375
-51
-12% -$42.2K 0.1% 114
2024
Q3
$378K Buy
+426
New +$383K 0.1% 107
2024
Q2
Sell
-483
Closed -$376K 116
2024
Q1
$376K Sell
483
-49
-9% -$34.9K 0.1% 103
2023
Q4
$310K Sell
532
-94
-15% -$54.9K 0.08% 112
2023
Q3
$336K Buy
626
+15
+2% +$7.73K 0.09% 111
2023
Q2
$268K Buy
+611
New +$256K 0.07% 120
2023
Q1
Sell
-1,454
Closed -$526K 169
2022
Q4
$526K Sell
1,454
-5,333
-79% -$1.89M 0.14% 100
2022
Q3
$2.26M Buy
6,787
+5,272
+348% +$1.67M 0.56% 44
2022
Q2
$485K Buy
1,515
+558
+58% +$167K 0.1% 113
2022
Q1
$274K Hold
957
0.05% 149
2021
Q4
$233K Buy
957
+1
+0.1% +$254 0.04% 156
2021
Q3
$221K Sell
956
-111
-10% -$27.4K 0.04% 156
2021
Q2
$245K Buy
+1,067
New +$214K 0.04% 156
2020
Q3
Sell
-19,921
Closed -$3.27M 167
2020
Q2
$3.27M Buy
19,921
+18,629
+1,442% +$2.86M 0.83% 34
2020
Q1
$178K Buy
+1,292
New +$178K 0.06% 141

Other funds holding LLY

Darwin Wealth Management's LLY Position: Q1 2026 in Review

Darwin Wealth Management reduced its Eli Lilly (LLY) stake by 9.7% in Q1 2026, selling an estimated $36.5K and leaving 335 shares worth $309K. The position accounts for 0.1% of the portfolio, ranked #116.

Darwin Wealth Management first reported a position in LLY in Q1 2020 and has held it in 20 quarters since. The position peaked at $3.27M in Q2 2020. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Darwin Wealth Management held 335 shares of Eli Lilly worth $309K as of Q1 2026.
  • Darwin Wealth Management sold 36 Eli Lilly shares in Q1 2026, an estimated $36.5K.
  • Eli Lilly made up 0.1% of Darwin Wealth Management's portfolio in Q1 2026, its #116 holding.
  • Darwin Wealth Management first reported a position in Eli Lilly in Q1 2020 and has held it in 20 quarters since.
  • Darwin Wealth Management's Eli Lilly position peaked at $3.27M in Q2 2020.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Darwin Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.